Sera Prognostics
SERA | NASDAQ
$1.94
-$0.07 (-3.48%)
At close: Nov 16, 2026, 4:00 PM ET
$1.94
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:26 PM ET
-3.48%
(1D)No price chart data available for 1D timeframe.
Rating
40.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #502/1021 (Top 49%)
Key Statistics
Market Data
Market Cap $98.53M
1D Range
1.91 2.14
52W Range
1.59 3.69
Valuation (TTM)
PE -2.90
PB 1.88
EV/EBITDA -1.71
Valuation (NTM)
Forward PE N/A
Forward PEG 0.58
Price Target $6.00
Cash Flow
FCF Yield -29.4%
SBC Adj. FCF Yield -33.4%
SBC Impact -13.7%
Margins
Gross Margin -103.1%
Operating Margin -38755.2%
FCF Margin -30199.0%
Growth (CAGR)
Revenue 3Y | 5Y -33.7% |
9.1%
Dil EPS 3Y | 5Y 19.8% |
20.3%
FCF 3Y | 5Y -28.0% |
7.1%
Returns
ROA -41.9%
ROE -52.5%
ROIC -66.8%
Financial Health
Net Cash
$44.09M
Current Ratio 1.88
Interest Coverage -5,315.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the...
Sector Healthcare
Industry Medical - Devices
Employees 72
IPO Date Jul 15, 2021
Website www.sera.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.16
Miss -14.29%
YoY:
0.00% REV
$42K
Miss -44.00%
YoY:
+162.50%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove SERA